secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001493152-25-011509
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack to exhibit CBGM at ADCES; touts progress toward US pilot study
-------------------------------------------------------------------------

- Presenting at ADCES Annual Meeting Aug 8-11, 2025 in Phoenix, AZ; CBGM at Booth #1724.
- Poster: 'Endocrinologists’ Perspectives on an Implantable CBGM' on Aug 9, 12:00-1:00 PM MST.
- Preparing to begin long-term early feasibility study after successful initial clinical validation.
- CBGM is fully implantable, lasts up to 3 years, measures blood glucose directly with no on-body wearable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225011509/0001493152-25-011509-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225011509/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011509

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer